UPXI - UPEXI, INC.
0.9623
-0.118 -12.231%
Share volume: 8,464,857
Last Updated: 03-05-2026
Pharmaceutical Products/Medicinal Chemicals:
2.23%
PREVIOUS CLOSE
CHG
CHG%
$1.08
-0.12
-0.11%
View ratios
| Fiscal Date | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 11-20-2023 | 07-09-2024 | 01-07-2025 | 12-19-2024 | 02-14-2025 | 05-16-2025 | 11-12-2025 | 02-10-2026 | |
| Assets | |||||||||
| Total Assets | 65.246 M | 56.507 M | 23.511 M | 18.603 M | 17.529 M | 15.067 M | 419.728 M | 271.145 M | |
| Current Assets | 24.918 M | 16.840 M | 11.420 M | 6.790 M | 6.110 M | 3.968 M | 220.341 M | 171.250 M | |
| Inventories | 13.786 M | 8.802 M | 1.432 M | 1.636 M | 2.236 M | 1.325 M | 1.036 M | 728.273 K | |
| Other Current Assets | 957.584 K | 0.000 | 8.218 M | 2.171 M | 2.000 M | 2.000 M | 215.304 M | 167.009 M | |
| Short Term Investments | 957.584 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 9.757 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 417.108 K | 498.287 K | 661.415 K | 1.790 M | 406.347 K | 230.392 K | 2.237 M | 1.617 M | |
| Total Non-current Assets | 40.328 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 750.000 K | 0.000 | |
| Property Plant Equipment | 7.745 M | 7.520 M | 2.357 M | 2.338 M | 2.140 M | 1.973 M | 1.931 M | 543.246 K | |
| Other Assets | 2.403 M | 32.148 M | 9.735 M | 9.475 M | 9.279 M | 9.127 M | 197.456 M | 99.351 M | |
| Intangible Assets | 12.385 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 11.719 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 65.246 M | 56.507 M | 23.511 M | 18.603 M | 17.529 M | 15.067 M | 419.728 M | 271.145 M | |
| Total liabilities | 37.676 M | 34.451 M | 16.995 M | 13.571 M | 13.766 M | 13.217 M | 208.936 M | 222.428 M | |
| Total current liabilities | 20.037 M | 24.192 M | 12.655 M | 9.771 M | 10.617 M | 10.796 M | 64.629 M | 77.852 M | |
| Accounts Payable | 4.938 M | 2.124 M | 481.647 K | 575.238 K | 1.005 M | 1.415 M | 2.185 M | 665.840 K | |
| Other liabilities | 0.000 | 5.465 M | 1.733 M | 1.843 M | 1.844 M | 1.844 M | 1.145 M | 460.134 K | |
| Current long term debt | 10.547 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 17.639 M | 4.794 M | 2.607 M | 1.958 M | 1.305 M | 576.170 K | 143.162 M | 144.115 M | |
| Other liabilities | 0.000 | 5.465 M | 1.733 M | 1.843 M | 1.844 M | 1.844 M | 1.145 M | 460.134 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 27.570 M | 22.056 M | 6.516 M | 5.032 M | 3.763 M | 1.851 M | 210.792 M | 48.717 M | |
| Common stock | 20.245 M | 53.170 M | 53.375 M | 53.517 M | 53.549 M | 55.469 M | 204.588 M | 222.237 M | |
| Retained earnings | -24.558 M | -31.114 M | -46.860 M | -48.485 M | -49.787 M | -53.618 M | 6.204 M | -172.721 M |